Daytona Beach, Florida Clinical Trials

A listing of Daytona Beach, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 8 clinical trials
MILD Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

This prospective longitudinal study will compare incidence rates of Medicare beneficiary surgical and minimally invasive intervention post index procedure, as well as harms associated with the MILD procedure, at 24 months post-treatment with MILD, tested against a control group of similar patients that have had a comparable procedure. This study …

Alliance Specialty Surgery Center
 (5.9 away) Contact site
  • 13 Jun, 2021
  • +831 other locations
Restore EF Observational Study

A multi-center, prospective, observational, non-interventional single arm, study of the intermediate-term clinical outcomes collected from electronic health records of high-risk patients which have previously undergone standard of care prophylactic Impella support for a non-emergent percutaneous coronary intervention (PCI).

Advent Health
 (3.4 away) Contact site
  • 27 Jan, 2021
  • +19 other locations
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

The purpose of this study is to evaluate the prevalence of 4 or more DNA-repair gene defects in a population of men with metastatic Prostate Cancer (PC) and to use the reported DNA-repair gene defects to assess biomarker eligibility for niraparib interventional studies.

Ocala Oncology Center
 (65.7 away) Contact site
  • 30 May, 2021
  • +471 other locations
Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred & Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant …

early diagnosis
primary cancer
early detection
Florida Hospital Memorial Medical Center
 (2.9 away) Contact site
  • 26 Jan, 2021
  • +85 other locations
MammaPrint BluePrint and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX Registry, which is intended to enable additional study …

Cancer Care Centers of Brevard
 (63.8 away) Contact site
  • 28 May, 2021
  • +111 other locations
Connect Myeloid Disease Registry

The purpose of the Connect Myeloid disease registry is to provide unique insights into treatment decisions and treatment patterns as they relate to clinical outcomes of patients with myeloid diseases in routine clinical practice. This disease registry will also evaluate molecular and cellular markers that may provide further prognostic classification …

myelodysplastic syndromes
bone marrow procedure
myeloid leukemia
Space Coast Medical Associates
 (41.2 away) Contact site
  • 10 Apr, 2021
  • +228 other locations
A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)

The purpose of this study (Bio-Hermes) is to develop a blood, digital, and brain amyloid PET scan biomarker database that can be used to determine whether a meaningful relationship exists between digital tests, blood amyloid-beta, p-tau, and neurofilament biomarker levels and amyloid-beta levels identified through brain amyloid PET images. Blood …

alzheimer's disease
mini-mental state examination
mild dementia
Progressive Medical Research
 (5.0 away) Contact site
  • 31 May, 2021
  • +8 other locations
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer

This study is designed to determine the accuracy of blood test ClarityDX Prostate to predict the results of prostate biopsies in men who have PSA (Prostate Specific Antigen) greater than 3 and no higher than 10 ng/mL.

prostate specific antigen
biopsy of prostate
Century Clinical Research Institute
 (3.4 away) Contact site
  • 26 Jan, 2021
  • +4 other locations